Deciphering the combination principles of Traditional Chinese Medicine from a systems pharmacology perspective based on Ma-huang Decoction.

ETHNOPHARMACOLOGY RELEVANCE The main therapeutic concept in Traditional Chinese Medicine (TCM) is herb formula, which treats various diseases via potential herb interactions to maximize the efficacy and minimize the adverse effects. However, the combination principle of herb formula still remains a mystery due to the lack of appropriate methods. METHODS A systems pharmacology method integrating the pharmacokinetic analysis, drug targeting, and drug-target-disease network is developed to dissect this rule embedded in the herbal formula. All these are exemplified by a representative TCM formula, Ma-huang decoction, made up of four botanic herbs. RESULTS Based on the deep investigation of the function and compatibility of each herb, in a molecular/systems level, we demonstrate the different pharmacological roles that each herb might play in the prescription. By the way of enhancing the bioavailability and/or making the pharmacological synergy among different herbs, the four herbs effectively combine together to be suitable for treating diseases. CONCLUSIONS The present work lays foundations for a more comprehensive understanding of the combination rule of TCM, which might also be beneficial to drug development and applications.

[1]  Xue Xu,et al.  A System-Level Investigation into the Mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for Cardiovascular Disease Treatment , 2012, PloS one.

[2]  S. Sharma,et al.  Modulation of P‐glycoprotein ATPase activity by some phytoconstituents , 2010, Phytotherapy research : PTR.

[3]  Darrell R Abernethy,et al.  Systems pharmacology to predict drug toxicity: integration across levels of biological organization. , 2013, Annual review of pharmacology and toxicology.

[4]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[5]  L. Hösli,et al.  Receptors for neurotransmitters on astrocytes in the mammalian central nervous system , 1993, Progress in Neurobiology.

[6]  Wei Ma,et al.  Pharmacokinetics and bioavailability of cinnamic acid after oral administration of ramulus cinnamomi in rats , 2010, European Journal of Drug Metabolism and Pharmacokinetics.

[7]  Xue Xu,et al.  Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. , 2013, Journal of ethnopharmacology.

[8]  R. Lazzaroni,et al.  A DFT study of the reactivity of OH groups in quercetin and taxifolin antioxidants : The specificity of the 3-OH site , 2006 .

[9]  M. B. Gupta,et al.  Anti-Inflammatory and Antipyretic Activities of β-Sitosterol , 1980 .

[10]  M. Blaiss,et al.  Complementary/alternative medicine in the treatment of asthma. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[11]  Cheng Lu,et al.  Effects of huoxiangzhengqi liquid on enteric mucosal immune responses in mice with Bacillus dysenteriae and Salmonella typhimurium induced diarrhea. , 2006, World journal of gastroenterology.

[12]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[13]  Y. Minamino,et al.  Volatile Components of Ephedra sinica Stapf. , 1997 .

[14]  D. Clapham,et al.  Camphor Activates and Strongly Desensitizes the Transient Receptor Potential Vanilloid Subtype 1 Channel in a Vanilloid-Independent Mechanism , 2005, The Journal of Neuroscience.

[15]  Yonghua Wang,et al.  A Systems Biology Approach to Understanding the Mechanisms of Action of Chinese Herbs for Treatment of Cardiovascular Disease , 2012, International journal of molecular sciences.

[16]  P. Xiao,et al.  The rediscovery of ancient Chinese herbal formulas , 2004, Phytotherapy research : PTR.

[17]  D. Shen,et al.  First‐pass metabolism of midazolam by the human intestine , 1996, Clinical pharmacology and therapeutics.

[18]  S. Karch,et al.  Demographic, pathologic, and toxicological profiles of 127 decedents testing positive for ephedrine alkaloids. , 2004, Forensic science international.

[19]  Li Yuhang,et al.  Discussion on the Three Levels of the Prescription-Composition Principle of TCM , 2009 .

[20]  Lawrence X. Yu,et al.  A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. , 2006, Molecular pharmaceutics.

[21]  W. Haefeli,et al.  Modulation of Cellular Cholesterol Alters P-Glycoprotein Activity in Multidrug-Resistant Cells , 2004, Molecular Pharmacology.

[22]  J. Blumberg,et al.  Flavonoids from almond skins are bioavailable and act synergistically with vitamins C and E to enhance hamster and human LDL resistance to oxidation. , 2005, The Journal of nutrition.

[23]  S. Benvenuti,et al.  Determination of ephedrine alkaloids in Ephedra natural products using HPLC on a pentafluorophenylpropyl stationary phase. , 2008, Journal of pharmaceutical and biomedical analysis.

[24]  Shufeng Zhou,et al.  Role of P-glycoprotein in the Intestinal Absorption of Glabridin, an Active Flavonoid from the Root of Glycyrrhiza glabra , 2007, Drug Metabolism and Disposition.

[25]  P. Watkins,et al.  The barrier function of CYP3A4 and P-glycoprotein in the small bowel. , 1997, Advanced drug delivery reviews.

[26]  Lianghui Chen,et al.  Absorption and Interaction of the Main Constituents from the Traditional Chinese Drug Pair Shaoyao-Gancao via a Caco-2 Cell Monolayer Model , 2012, Molecules.

[27]  Xin-jun Liu,et al.  [Study of combination methods for formula composition of Chinese herbal medicines and their components]. , 2009, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

[28]  M. Spinella The importance of pharmacological synergy in psychoactive herbal medicines. , 2002, Alternative medicine review : a journal of clinical therapeutic.

[29]  P. Xiao,et al.  Research and application of Radix Glycyrrhizae , 2007 .

[30]  G. Kroemer,et al.  Heat shock proteins: endogenous modulators of apoptotic cell death. , 2001, Biochemical and biophysical research communications.

[31]  Xuejun Yu,et al.  Development of the chromatographic fingerprint of herbal preparations Shuang-Huang-Lian oral liquid. , 2006, Journal of pharmaceutical and biomedical analysis.

[32]  Neil Benson,et al.  Systems Pharmacology: Bridging Systems Biology and Pharmacokinetics-Pharmacodynamics (PKPD) in Drug Discovery and Development , 2011, Pharmaceutical Research.

[33]  M. Olling,et al.  The pharmacokinetics of amygdalin , 2004, Archives of Toxicology.

[34]  S Jothy,et al.  Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. , 1995, Cancer research.

[35]  Jing Zhang,et al.  Chinese medicinal herbs for the common cold. , 2007, The Cochrane database of systematic reviews.

[36]  Guangwei Huang,et al.  A review of composition studies of cultivated almonds: Macronutrients and micronutrients , 2011 .

[37]  H. Inoue,et al.  Glycyrrhiza inflata-derived chalcones, Licochalcone A, Licochalcone B and Licochalcone D, inhibit phosphorylation of NF-kappaB p65 in LPS signaling pathway. , 2009, International immunopharmacology.

[38]  Bo Chen,et al.  Sample preparation for analyzing traditional Chinese medicines , 2009 .

[39]  F. Guengerich,et al.  Cytochrome P-450 3A4: regulation and role in drug metabolism. , 1999, Annual review of pharmacology and toxicology.

[40]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[41]  Yong Yang,et al.  Chemical variation in the essential oil ofEphedra sinica from Northeastern China , 2006 .

[42]  Feng Hui Pharmacokinetics and Bioavailability of Cinnamic Acid in Mice , 2004 .

[43]  Yeong-Deug Yi,et al.  An Overview of Traditional Chinese Herbal Formulae and a Proposal of a New Code System for Expressing the Formula Titles , 2004, Evidence-based complementary and alternative medicine : eCAM.

[44]  Li-ping Yang,et al.  Application of systems biology technology in research of traditional Chinese medicine. , 2009, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[45]  H. van de Waterbeemd,et al.  ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.

[46]  Hua Yu,et al.  A Novel Chemometric Method for the Prediction of Human Oral Bioavailability , 2012, International journal of molecular sciences.

[47]  Xue Xu,et al.  Multidrug resistance protein P-glycoprotein does not recognize nanoparticle C60: experiment and modeling , 2012 .

[48]  N. Shibata,et al.  Application of pressure‐controlled colon delivery capsule to oral administration of glycyrrhizin in dogs , 2001, The Journal of pharmacy and pharmacology.

[49]  Jiunn H. Lin,et al.  Drug-drug interaction mediated by inhibition and induction of P-glycoprotein. , 2003, Advanced drug delivery reviews.

[50]  Mi-Young Jeong,et al.  Microarray analysis of gene expression profile by treatment of Cinnamomi Ramulus in lipopolysaccharide-stimulated BV-2 cells. , 2009, Gene.

[51]  Y. Z. Chen,et al.  A computer method for validating traditional Chinese medicine herbal prescriptions. , 2005, The American journal of Chinese medicine.

[52]  Chao Ma,et al.  GPU Accelerated Chemical Similarity Calculation for Compound Library Comparison , 2011, J. Chem. Inf. Model..

[53]  Jianpin Liu,et al.  Traditional Chinese Medicine in Cancer Care: A Review of Case Reports Published in Chinese Literature , 2011, Complementary Medicine Research.

[54]  M. Wink,et al.  Inhibition of P-glycoprotein activity by limonin and other secondary metabolites from Citrus species in human colon and leukaemia cell lines. , 2010, European journal of pharmacology.

[55]  B. Wung,et al.  Chalcone inhibits the activation of NF-kappaB and STAT3 in endothelial cells via endogenous electrophile. , 2007, Life sciences.

[56]  C. Dey,et al.  P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. , 2003, Pharmacological research.

[57]  Hossein Hosseinzadeh,et al.  Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds , 2008, Phytotherapy research : PTR.

[58]  Jiangyong Gu,et al.  Computational pharmacological studies on cardiovascular disease by Qishen Yiqi Diwan , 2009 .

[59]  K. Bae,et al.  Anti-gastric actions of eugenol and cinnamic acid isolated from Cinnamomi Ramulus. , 2011, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[60]  Y. Miyagi,et al.  Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse. , 1998, The American journal of pathology.

[61]  Hua Yu,et al.  A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data , 2012, PloS one.

[62]  Junxian He,et al.  Bioavailability of glycyrrhizin from Shaoyao‐Gancao‐Tang in laxative‐treated rats , 2005, The Journal of pharmacy and pharmacology.

[63]  J. Greef,et al.  Rescuing drug discovery: in vivo systems pathology and systems pharmacology , 2005, Nature Reviews Drug Discovery.

[64]  N. Hollenberg,et al.  (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[65]  Jinan Wang,et al.  Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice. , 2013, Journal of ethnopharmacology.

[66]  Wen-yue Jiang,et al.  Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. , 2005, Trends in pharmacological sciences.

[67]  V. Álvarez,et al.  5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction. , 2003, Clinical science.

[68]  S. Tsukamoto,et al.  CYP3A4 inhibitors isolated from Licorice. , 2005, Biological & pharmaceutical bulletin.

[69]  Seiichi Yamaji,et al.  Analysis and comparison of Radix Glycyrrhizae (licorice) from Europe and China by capillary-zone electrophoresis (CZE). , 2005, Journal of pharmaceutical and biomedical analysis.

[70]  Ramkumar Hariharan,et al.  Detailed Comparison of the Protein-Ligand Docking Efficiencies of GOLD, a Commercial Package and ArgusLab, a Licensable Freeware , 2006, Silico Biol..

[71]  Paul M Ridker,et al.  Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women. , 2007, Clinical chemistry.

[72]  Shao Li,et al.  Network Systems Underlying Traditional Chinese Medicine Syndrome and Herb Formula , 2009 .

[73]  Hideyuki Ito,et al.  Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[74]  M. Soni,et al.  Safety of ephedra: lessons learned. , 2004, Toxicology letters.

[75]  Jane Qiu,et al.  Traditional medicine: A culture in the balance , 2007, Nature.

[76]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[77]  N. Sucher The application of Chinese medicine to novel drug discovery , 2013, Expert opinion on drug discovery.

[78]  Eamonn F. Healy,et al.  Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .

[79]  Wu Ganqiu Research advance in pharmacological effect of borneol and the underlying mechanism , 2010 .

[80]  D. Kennedy,et al.  Acute, dose‐dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand , 2002, Human psychopharmacology.

[81]  F. Azuaje,et al.  Drug-target network in myocardial infarction reveals multiple side effects of unrelated drugs , 2011, Scientific reports.

[82]  Chao Huang,et al.  Systems pharmacology in drug discovery and therapeutic insight for herbal medicines , 2014, Briefings Bioinform..

[83]  Yizeng Liang,et al.  Resolution of the essential constituents of Ramulus cinnamomi by an evolving chemometric approach , 2001, Fresenius' journal of analytical chemistry.

[84]  M G Ford,et al.  Selecting compounds for focused screening using linear discriminant analysis and artificial neural networks. , 2004, Journal of molecular graphics & modelling.

[85]  Lian‐Wen Qi,et al.  Analysis of Chinese herbal medicines with holistic approaches and integrated evaluation models , 2008 .

[86]  Ravi Iyengar,et al.  Network analyses in systems pharmacology , 2009, Bioinform..

[87]  J. Haight,et al.  Dose Response of Almonds on Coronary Heart Disease Risk Factors: Blood Lipids, Oxidized Low-Density Lipoproteins, Lipoprotein(a), Homocysteine, and Pulmonary Nitric Oxide: A Randomized, Controlled, Crossover Trial , 2002, Circulation.

[88]  P. Hollenberg,et al.  The licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6, and 2C9. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[89]  J. Kovach,et al.  Pharmacology of amygdalin (laetrile) in cancer patients , 2004, Cancer Chemotherapy and Pharmacology.

[90]  D. Feller,et al.  Direct effects of ephedrine isomers on human β-adrenergic receptor subtypes , 1999 .

[91]  W. Frishman,et al.  Herbal medicine for the treatment of cardiovascular disease: clinical considerations. , 1998, Archives of internal medicine.

[92]  D. Tindall,et al.  Androgen receptor signaling in androgen-refractory prostate cancer. , 2001, Journal of the National Cancer Institute.

[93]  I. Kanfer,et al.  In vitro evaluation of human cytochrome P450 and P-glycoprotein-mediated metabolism of some phytochemicals in extracts and formulations of African potato. , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[94]  E. Lien,et al.  Structure–activity relationship: analyses of p‐glycoprotein substrates and inhibitors , 2003, Journal of clinical pharmacy and therapeutics.

[95]  Zhi-xiang Shen,et al.  Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia , 2008, Proceedings of the National Academy of Sciences.

[96]  P. Kefalas,et al.  Irrigation and harvest time affect almond kernel quality and composition , 2002 .

[97]  David L. Brown,et al.  Cardiovascular effects of ephedra alkaloids: a comprehensive review. , 2005, Progress in cardiovascular diseases.

[98]  L. Walker,et al.  Ephedra in perspective – a current review , 2003, Phytotherapy research : PTR.

[99]  Jing Yang,et al.  Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats. , 2006, Pharmacological research.

[100]  Peng Jiang,et al.  Molecular networks for the study of TCM Pharmacology , 2010, Briefings Bioinform..

[101]  K. Ueno,et al.  Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals , 2008, Cancer Chemotherapy and Pharmacology.

[102]  Bo Zhang,et al.  Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae , 2010, BMC Bioinform..